Fineheart Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 50

Employees

  • Latest Deal Type
  • Series C
  • (Upcoming)

  • Latest Deal Amount
  • $16.1M

  • Investors
  • 16

Fineheart General Information

Description

Developer of implantable cardiac devices designed to treat cardiovascular diseases. The company's device is a novel, wirelessly powered, fully implantable mechanical circulatory support device that is able to optimize cardiac output while preserving the heart's innate contractility, enabling patients to restore normal cardiac output and allow heart failure patients to return to a normal quality of life.

Contact Information

Website
www.fineheart.fr
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
  • 28 Avenue Gustave Eiffel
  • Bâtiment C
  • 33600 Pessac
  • France
+33 05 00 00 00 00

Fineheart Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fineheart Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series C) $16.1M Upcoming Pre-Clinical Trials
8. Grant 08-Dec-2022 00.000 000.00 Completed Pre-Clinical Trials
7. Accelerator/Incubator 19-Oct-2022 00.000 000.00 Completed Pre-Clinical Trials
6. Later Stage VC (Series B) 15-Dec-2021 000.00 000.00 000.00 Completed Pre-Clinical Trials
5. Later Stage VC 01-Jan-2018 000.00 Cancelled Pre-Clinical Trials
4. Accelerator/Incubator 17-Sep-2018 0000 00.000 Completed Pre-Clinical Trials
3. Accelerator/Incubator 29-Sep-2017 00.000 Completed Pre-Clinical Trials
2. Later Stage VC (Series A) 28-Jan-2016 $6.97M $6.97M 000.00 Completed Pre-Clinical Trials
1. Accelerator/Incubator 01-Jan-2010 Completed Startup
To view Fineheart’s complete valuation and funding history, request access »

Fineheart Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B 000,000 000.000000 0000.00 0000.00 00 0000.00 00.000
Series A 00,000 000.000000 0000.00 0000.00 00 0000.00 00.000
To view Fineheart’s complete cap table history, request access »

Fineheart Patents

  • 116

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 13

    Granted

  • 3

    Pending

  • 000

    Expiring in next 12 mo

Fineheart Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-3130624-A1 Shrunken head intraventricular heart pump. Pending 21-Dec-2021 0000000000 0
CA-3180617-A1 Device for fixing and positioning a cardiac pump Pending 10-Nov-2021 0000000000
EP-4180086-A1 Device for fixing and positioning a heart pump Pending 10-Nov-2021 0000000000 0
FR-3128885-A1 Device for securing and positioning a heart pump Pending 10-Nov-2021 0000000000 0
US-20230145482-A1 Device for fixing and positioning a cardiac pump Pending 10-Nov-2021 A61M60/178
To view Fineheart’s complete patent history, request access »

Fineheart Executive Team (8)

Name Title Board Seat Contact Info
Arnaud Mascarell Co-Founder, Chief Executive Officer, Directeur Général, Managing Director & Board Member
Guillaume Buc Chief Technical Officer
Stéphane Garrigue Ph.D Co-Founder, Chief Scientific Officer & Scientific Advisory Board Member
Sophie Jonquière Chief Procurement & Supply Chain Officer
Mohammad Haddadi Ph.D Chief Research and Development Officer
You’re viewing 5 of 8 executive team members. Get the full list »

Fineheart Board Members (10)

Name Representing Role Since
Alexandre Scherer M Capital Partners Board Observer 000 0000
Arnaud Mascarell Fineheart Co-Founder, Chief Executive Officer, Directeur Général, Managing Director & Board Member 000 0000
Bertrand Boutaud Self Board Member 000 0000
Jean-Luc Boulnois Ph.D Self Chairman 000 0000
Maria Berkman MD Broadview Ventures Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Fineheart Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Fineheart Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
European Regional Development Fund (Brandenburg) Sovereign Wealth Fund 000 0000 000000 0
European Innovation Council Fund Venture Capital Minority 000 0000 000000 0
Doliam Corporation Minority 000 0000 000000 0
Lauak PE-Backed Company Minority 000 0000 000000 0
Nouvelle Aquitaine Co-Investissement PE/Buyout Minority 000 0000 000000 0
You’re viewing 5 of 16 investors. Get the full list »

Ready to get started?

Request a free trial